News
“The Chromium Single-Cell 3’ Solution was announced last year at AGBT as the first comprehensive and commercially available droplet-based NGS solution for scRNA-seq, and has quickly become the ...
At the larger-scale end, 10x has rolled out its GEM-X Flex Gene Expression offering, a next-generation successor to its Chromium Flex single-cell gene expression technology that is designed to ...
SAN FRANCISCO, Aug. 1, 2022 /PRNewswire/ -- High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology for more than a decade. The opportunity ...
PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new ...
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to ...
Element is a validated partner for 10x Genomics, BD Rhapsody, and Parse Evercode systems.; The AVITI System throughput neatly matches the sample outputs from leading and emerging single cell ...
We are proud to be collaborating with 10x Genomics to enable greater discoveries in human genomics with the ability to explore new dimensions of biology with single-cell nanopore sequencing. Full ...
FOSTER CITY, Calif., Nov. 7, 2023 /PRNewswire/ -- MedGenome, a global precision medicine company specializing in omics solutions, announced today that it has achieved the 10x Genomics Certified ...
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products ...
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results